The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what The Blacklisting of Peptides BPC 157 OLYMPEX SOLUTIONS FDA UPDATED PEPTIDES APRIL 15, 2026 Most people are already getting this wrong. Today, the FDA updated its 503A compounding categories and removed several peptides from the high risk (Category 2) When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions